hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 7.50
+0.80 (11.94%)
Jul 24, 2026, 4:35 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 51.53 million as of July 24, 2026. Its market cap has decreased by -22.33% in one year.
Market Cap
51.53M
Enterprise Value
52.02M
Revenue
49.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.50
ChartMarket Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 51.53M, an increase of 198.92%. That is a compound annual growth rate of 16.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 51.53M | 20.21% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 97.55M |
| Faron Pharmaceuticals Oy | 90.86M |
| 4basebio | 81.58M |
| Bioventix | 79.68M |
| Ondine Biomedical | 71.44M |
| Hemogenyx Pharmaceuticals | 49.44M |
| Poolbeg Pharma | 46.95M |
| Sareum Holdings | 30.48M |